Minnesota’s medical marijuana industry is off to a slow start, but that’s not stopping one of its two players from landing millions of dollars.
LeafLine Labs added about $2.5 million in equity financing to its most recent round of funding, which brought in about $12.4 million in December. The grower disclosed the additional funds in an Oct. 31 securities filing.
Read Katharine Grayson’s “Marijuana venture LeafLine lands $2.5M more”: http://www.bizjournals.com/twincities/news/2015/11/09/leafline-lands-2-5m-more-marijuana.html